Efficacy and Safety of Mirikizumab as Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-2 Study.
Unknown authors
Topics & Concepts
Ulcerative colitisMedicineInternal medicineMaintenance therapyGastroenterologySurgeryDiseaseChemotherapyInflammatory Bowel DiseaseMicroscopic ColitisHelicobacter pylori-related gastroenterology studies